Simultaneous changes in secretory amyloid precursor protein and β-amyloid peptide release from rat hippocampus by activation of muscarinic receptors

Neuroscience Letters

Volumn 352, Issue 1, 2003, Pages 41-44

  Qiu, Yu ^a   Wu, Xing Jun ^a   Chen, Hong Zhuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Carbachol; Hippocampus; Muscarinic receptors; Amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ATROPINE; CARBACHOL; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL STRAIN; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; NEUROTOXICITY; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE;

EID: 0242459186     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.08.022     Document Type: Article

References (20)

1. De Felice F.G., Ferreira S.T. Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease. Cell. Mol. Neurobiol. 22:2002;545-563.
2. 1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cells. Biochem. Biophys. Res. Commun. 244:1998;156-160.
3. Dolezal V., Kasparova J. Beta-amyloid and cholinergic neurons. Neurochem. Res. 28:2003;499-506.
4. 1 muscarinic agonists as potential disease-modifying agents in Alzheimer's disease. Rationale and perspectives. Ann. N. Y. Acad. Sci. 920:2000;315-320.
5. Gianni D., Zambrano N., Bimonte M., Minopoli G., Mercken L., Talamo F., Scaloni A., Russo T. Platelet-derived growth factor induces the beta-gamma-secretase-mediated cleavage of Alzheimer's amyloid precursor protein through a Src-Rac-dependent pathway. J. Biol. Chem. 278:2003;9290-9297.
6. Hellstorm-Lindahl E. Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors. Eur. J. Pharmacol. 393:2000;55-63.
7. Herreman A., Van Gassen G., Bentahir M., Nyabi O., Craessaerts K., Mueller U., Annaert W., De Strooper B. gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. J. Cell Sci. 116:2003;1127-1136.
8. Hoshi M., Takashima A., Murayama M., Yasutake K., Yoshida N., Imahori K. Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease. J. Biol. Chem. 272:1997;2038-2041.
9. Isacson O., Lin L. Cholinergic modulation of amyloid processing and dementia in animal models of Alzheimer's disease. Ann. N. Y. Acad. Sci. 920:2000;309-314.
10. Latasa M.J., Belandia B., Pascual A. Thyroid hormones regulate beta-amyloid gene splicing and protein secretion in neuroblastoma cells. Endocrinology. 139:1998;2692-2698.
11. Leanza G. Chronic elevation of amyloid precursor protein expression in the neocortex and hippocampus of rats with selective cholinergic lesions. Neurosci. Lett. 257:1998;53-56.
12. Lee T.F., Shiao Y.J., Chen C.F., Wang L.C. Effect of ginseng saponins on beta-amyloid-suppressed acetylcholine release from rat hippocampal slices. Planta Med. 67:2001;634-637.
13. Lyness S.A., Zarow C., Chui H.C. Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol. Aging. 24:2003;1-23.
14. Michaelis M.L. Drugs targeting Alzheimer's disease: some things old and some things new. J. Pharmacol. Exp. Ther. 304:2003;897-904.
15. 1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain. Life Sci. 60:1997;985-991.
16. Piccini A., Ciotti M.T., Vitolo O.V., Calissano P., Tabaton M., Galli C. Endogenous APP derivatives oppositely modulate apoptosis through an autocrine loop. NeuroReport. 11:2000;1375-1379.
17. Qiu Y., Chen H.-Z., Wu X.-J., Jin Z.-J. 6-Acetoxy nortropane regulated processing of amyloid precursor protein in CHOm1 cells and rat brain. Eur. J. Pharmacol. 61270:2003;1-8.
18. Sberna G., Sez V.J., Beyreuther K., Masters C.L., Small D.H. The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J. Neurochem. 69:1997;1177-1184.
19. Vagnucci A.H., Li W.W. Alzheimer's disease and angiogenesis. Lancet. 361:2003;605-608.
20. Verbois S.L., Scheff S.W., Pauly J.R. Chronic nicotine treatment attenuates alpha 7 nicotinic receptor deficits following traumatic brain injury. Neuropharmacology. 44:2003;224-233.